Michael S Isakoff

12PUBLICATIONS
72CO-AUTHORS
Molecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.

Katherine A Janeway, Alexander J Chou, Allen Buxton

|Sep 27, 2025
Cytokine Profiling of Children, Adolescents, and Young Adults Newly Diagnosed with Sarcomas Demonstrates the Role of IL-1β in Osteosarcoma Metastasis.

Laurel Kastner, William Kandalaft, Aakash Mahant Mahant

|Jul 12, 2025
Immunosuppressive Tumor Microenvironment of Osteosarcoma.

Aaron Michael Taylor, Jianting Sheng, Patrick Kwok Shing Ng

|Oct 03, 2024
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

Aditi Dhir, Masanori Hayashi, Avery Bodlak

|Aug 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.

Ajay Gupta, Matthew S Dietz, Richard F Riedel

|Jul 05, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board.

Ajay Gupta, Richard F Riedel, Chirag Shah

Pageof 2

Frequent Collaborators

4 joint publications

Masanori Hayashi

3 joint publications

Katherine A Janeway

3 joint publications

Damon R Reed

3 joint publications

Scott C Borinstein